U.S. markets closed

Koninklijke DSM N.V. (DSM.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR
Add to watchlist
136.05-0.60 (-0.44%)
At close: 05:35PM CEST
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close136.65
Bid0.00 x 0
Ask0.00 x 0
Day's Range136.05 - 139.70
52 Week Range133.90 - 200.50
Avg. Volume432,298
Market Cap23.532B
Beta (5Y Monthly)0.63
PE Ratio (TTM)14.12
EPS (TTM)9.64
Earnings DateAug 02, 2022
Forward Dividend & Yield2.50 (1.84%)
Ex-Dividend DateMay 12, 2022
1y Target Est185.13
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for DSM.AS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      DSM announces final dividend for 2021

      Royal DSM, a global purpose-led science-based company, confirmed its resolution to declare a dividend for the financial year 2021 of €2.50 per ordinary share was passed today, 10 May 2022, at its Annual General Meeting of Shareholders. This represents an increased dividend versus the €2.40 paid for 2020. An interim dividend of €0.80 per ordinary share having been paid in August 2021, the final dividend thus amounts to €1.70 per ordinary share.

    • PR Newswire

      DSM announces results of 2022 Annual General Meeting of Shareholders

      Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders.

    • PR Newswire

      DSM - repurchase of shares (2-6 May 2022)

      Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08. This is in accordance with the repurchase program announced on 10 March 2022, covering the commitments for the final stock dividend 2021 and share based compensation plans. The consideration of this repurchase was €6.3 million.